Buy Stromectol (Ivermectin) Online – Safe Antiparasitic Treatment

Ivermectin is a broad-spectrum antiparasitic agent used to treat onchocerciasis (river blindness), strongyloidiasis, scabies, head lice, and various intestinal nematode infections. It belongs to the avermectin class and works by potentiating glutamate-gated chloride ion channels in invertebrate nerve and muscle cells, causing paralysis and death of parasites. It is a prescription-only medicine with critical warnings: neurotoxicity risk in certain breeds of dogs (collie-type) – not applicable to humans, potential drug interactions via P-glycoprotein, contraindication in patients with Loa loa co-infection (risk of encephalopathy), and not approved for viral infections despite widespread misinformation.

Ivermectin at a Glance

Why Ivermectin (and When Not)

• Pros: Highly effective single-dose or short-course therapy for many neglected tropical diseases; well-tolerated in recommended doses; WHO Essential Medicine; transformative impact on river blindness and lymphatic filariasis elimination programs.
• Trade-offs: Mazzotti reaction (inflammatory response to dying microfilariae) in onchocerciasis; rare CNS effects at high doses; contraindicated in Loa loa co-endemic regions without screening; limited efficacy against adult filarial worms; not effective against all parasites.
• Modern approach: Use for confirmed parasitic infections with appropriate dosing based on body weight. Combine with mass drug administration programs for public health impact where indicated. Strictly avoid use for unapproved indications without robust clinical evidence.

Mechanism of Action

Ivermectin selectively binds to glutamate-gated chloride ion channels in invertebrate nerve and muscle cells, increasing chloride ion permeability, causing hyperpolarization, flaccid paralysis, and death of parasites. It also interacts with GABA-gated chloride channels in some nematodes. The drug has minimal affinity for mammalian chloride channels under normal conditions, but P-glycoprotein (P-gp) efflux at the blood-brain barrier provides additional CNS protection. In arthropods and nematodes, the effect is irreversible, leading to sustained antiparasitic activity.

Pharmacokinetics & Clinical Implications

Evidence-Based Indications

• Onchocerciasis (river blindness): Single dose 150 mcg/kg every 6–12 months; reduces microfilarial load, prevents ocular and skin disease; community-directed treatment programs.
• Strongyloidiasis (intestinal threadworm): 200 mcg/kg single dose; often repeated after 2 weeks; cure rates >90%.
• Scabies (Sarcoptes scabiei): 200 mcg/kg single dose; may repeat in 7–14 days for crusted scabies; topical permethrin often first-line but ivermectin useful for institutional outbreaks, crusted scabies, or treatment failures.
• Head lice (Pediculus humanus capitis): Topical lotion (0.5%) is FDA-approved; oral use off-label, single or repeat dose based on resistance patterns.
• Intestinal nematodes: Ascariasis, trichuriasis, enterobiasis (pinworm): 150–200 mcg/kg single dose; may combine with albendazole for enhanced efficacy.
• Lymphatic filariasis (as part of mass drug administration): In combination with albendazole or diethylcarbamazine (DEC) for elimination programs.

Formulations & Strengths

Dosing & Timing Strategies

Follow your prescriber and local labeling. Ranges below are educational, not personal medical advice.

Special Populations & Comorbidities

• Loa loa co-infection: Absolute contraindication in patients with high Loa loa microfilarial density (endemic regions of Central Africa). May cause severe encephalopathy. Screen or use alternative therapy.
• Hepatic impairment: Limited data; use with caution in severe disease; consider lower dose or alternative therapy.
• Renal impairment: No specific dose adjustment typically required; caution in severe impairment.
• Pregnancy: Avoid unless absolutely necessary; limited human data. WHO recommends use in mass drug administration programs during pregnancy only when benefit outweighs risk (e.g., onchocerciasis endemic areas).
• Breastfeeding: Excreted in breast milk; avoid or use with caution; delay breastfeeding for several days post-dose if possible.
• Pediatric: Approved down to 5 kg body weight (approximately 6 months) for some indications; weight-based dosing.
• Elderly: No specific contraindications; use standard weight-based dosing.
• Immunocompromised: Strongyloidiasis may require repeated doses; hyperinfection syndrome risk; monitor closely.

Drug Interactions & P-gp Considerations

Adverse Effects & Warning Signs

• Mazzotti reaction: Inflammatory response to dying microfilariae; common in onchocerciasis. Usually self-limited; antihistamines or anti-inflammatories may be used for symptom control. Not an allergy.
• Neurotoxicity warning signs: Confusion, unsteady gait, tremors, slurred speech, excessive sedation → stop and seek medical evaluation.

Misuse Potential & Controversies

Ivermectin has been subject to significant off-label use and misinformation, particularly surrounding COVID-19. Large, well-controlled trials (including TOGETHER, ACTIV-6, and others) have consistently shown no clinical benefit for viral infections. Inappropriate use carries risks: adverse effects (including rare but serious neurotoxicity), delayed appropriate treatment, and diversion of medication from parasitic disease programs. Use only for approved indications under medical supervision.

Discontinuation Notes

Ivermectin is typically administered as single or intermittent doses. No taper is required after course completion. For conditions requiring repeated doses (onchocerciasis, strongyloidiasis, crusted scabies), follow prescribed interval protocols. Abrupt cessation of a scheduled repeat-dosing regimen does not cause withdrawal but may allow parasite recrudescence.

Comparison with Other Antiparasitics

Performance, Driving & Safety

Ivermectin may cause dizziness, ataxia, or fatigue in some individuals, particularly at higher doses or with concomitant P-gp inhibitors. Wait to assess effects before driving or operating machinery. Avoid alcohol during treatment as it may exacerbate CNS effects.

Legal/Regulatory Status (Rx-Only)

Ivermectin is a prescription-only medicine in most countries. It is not a controlled substance, but distribution is regulated. Some jurisdictions have implemented additional restrictions on prescribing for unapproved indications due to safety concerns and supply shortages for approved uses. Obtain only with a valid prescription from a licensed clinician.

Safe Access via Clinicians & Licensed Pharmacies

1. Parasitological diagnosis: Confirm parasitic infection through appropriate testing (microscopy, serology, molecular) when possible. For onchocerciasis and strongyloidiasis, clinical and epidemiologic context guides treatment.
2. Loa loa risk assessment: In endemic regions, screen for Loa loa infection before ivermectin administration to prevent encephalopathy.
3. Weight-based dosing: Accurate body weight required for correct dose calculation.
4. Prescription: From licensed clinician to licensed pharmacy; pharmacist counseling on administration, Mazotti reaction expectations, and adverse effects.
5. Follow-up: Confirm cure where indicated (e.g., stool examination for strongyloidiasis). Schedule repeat doses as needed for onchocerciasis or crusted scabies.

FAQ – Practical Questions

1. What parasites does ivermectin kill? Onchocerca volvulus (river blindness), Strongyloides stercoralis, Sarcoptes scabiei (scabies), Pediculus humanus (lice), Ascaris lumbricoides, Trichuris trichiura, Enterobius vermicularis, and others. Not effective against tapeworms, flukes, or most protozoa.
2. How long does it take to work? Parasite paralysis occurs within hours; clearance of microfilariae takes days to weeks. Scabies symptoms may persist 2–4 weeks due to hypersensitivity reactions even after parasite death.
3. Can I take it on an empty stomach? Yes; take with water. Food increases absorption but not required.
4. What is the Mazzotti reaction? Inflammatory response to dying microfilariae: itching, rash, fever, joint pain, swollen lymph nodes. Common in onchocerciasis treatment. Usually mild and self-limited; treat symptoms with antihistamines or NSAIDs.
5. Is ivermectin safe during pregnancy? Avoid unless benefit clearly outweighs risk. WHO recommends in mass drug administration programs during pregnancy only in high-endemic areas for onchocerciasis.
6. Can I take ivermectin for COVID-19? No. FDA, WHO, and major medical societies do not recommend ivermectin for COVID-19. Large trials show no benefit.
7. What is the difference between human and veterinary ivermectin? Veterinary products are formulated for animals, have different concentrations, and contain inactive ingredients not tested for human safety. Never use animal ivermectin in humans.
8. How often should I repeat for scabies? Uncomplicated scabies: single dose, repeat in 7–14 days if persistent. Crusted scabies: multiple doses over weeks with topical permethrin.
9. Do I need to treat household contacts? Yes for scabies and lice. For intestinal nematodes, treat household contacts only if symptomatic or confirmed infection.
10. Can I drink alcohol while taking ivermectin? Avoid or limit; alcohol may exacerbate dizziness or fatigue.
11. What if I miss a repeat dose? Take as soon as remembered; if close to next scheduled dose, skip and continue schedule. For onchocerciasis, maintain interval (every 6–12 months).
12. Does ivermectin cause weight gain? Not typically.
13. Can I take ivermectin with other medications? Discuss all medications with prescriber, especially P-gp inhibitors (verapamil, cyclosporine, ketoconazole) and CYP3A4 modulators.
14. How is ivermectin dosed by weight? Typical dose 150–200 mcg/kg. For a 70 kg person, 10.5–14 mg (4–5 x 3 mg tablets). Dose based on exact body weight.
15. Is ivermectin effective against bed bugs? No.
16. What is the half-life? 12–36 hours; prolonged in adipose tissue.
17. Can I take ivermectin prophylactically for parasites? Mass drug administration programs use periodic dosing for public health, not individual prophylaxis. Not recommended for personal prevention without clear indication.
18. What are signs of overdose? Severe CNS depression, ataxia, coma, seizures. Seek emergency care immediately.
19. Does ivermectin interact with warfarin? Possible increased anticoagulant effect; monitor INR.
20. How long does it stay in system? Detectable for days; tissue distribution extends effects but drug cleared from plasma within days.
21. Can I get ivermectin over the counter? No; prescription required in most countries.
22. Why is ivermectin called a “wonder drug”? Due to its profound impact on neglected tropical diseases, earning its discoverers the Nobel Prize in 2015. This refers to approved antiparasitic uses, not unapproved indications.
23. Is it safe in children? Yes, down to 5 kg for approved indications; weight-based dosing.
24. What is the difference between ivermectin and albendazole? Different mechanisms; often used together for filariasis and intestinal parasites.
25. Does ivermectin cause hair loss? Not a known common effect.
26. Can I take ivermectin for rosacea? Topical ivermectin (Soolantra®) is approved for rosacea; oral ivermectin is not approved for this indication.
27. What is the risk of Loa loa encephalopathy? In patients with high Loa loa microfilarial density (Central Africa), ivermectin can cause severe encephalopathy. Screening required in endemic areas.
28. How do I store ivermectin? Room temperature, dry place; protect from light.
29. Can I crush the tablets? Yes, if needed; but take whole with water for accurate dosing.
30. What if I vomit after taking? If within 2 hours, may need redosing; consult prescriber.
31. Does ivermectin treat ringworm? No; ringworm is fungal, requires antifungals.
32. How is it different from moxidectin? Moxidectin has longer half-life and is approved for onchocerciasis; similar mechanism.
33. Can I use ivermectin for my dog? No; veterinary products are formulated specifically for animals. Human formulations not for animal use.
34. What is the success rate for strongyloidiasis? >90% with single 200 mcg/kg dose.

Printable Safe-Use Checklist

Disclaimer: This educational document does not replace personalized medical advice. Ivermectin is a prescription antiparasitic medication with specific approved indications. It is not approved for viral infections, and veterinary formulations are not safe for human use. Use only under licensed clinician supervision and according to local laws and product labeling.